3 completed, 1 recruiting, 1 terminated. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 3, Recruiting 1, Terminated 1 |
Follow Reboxetine: new trials by email Literature Review of Reboxetine trials Research Report on Reboxetine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Role of the Brain in Mental and Physical Fatigue Reboxetine Pill, Methylphenidate Oral Product - Fatigue | Phase 3 | Recruiting | Vrije Universiteit Brussel | 62 | 2023-05-03 | 2025-06-18 |
| A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE) AXS-12 (reboxetine), Placebo - Narcolepsy, Cataplexy | Phase 3 | Completed | Axsome Therapeutics, Inc. | 68 | 2021-10-20 | 2025-11-13 |
| A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy AXS-12 (reboxetine), Placebo - Narcolepsy, Cataplexy | Phase 3 | Completed | Axsome Therapeutics, Inc. | 90 | 2021-09-15 | 2026-05-28 |
| Pharmacovigilance in Gerontopsychiatric Patients Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression | Phase 3 | Terminated | Hannover Medical School | 407 | 2015-01-01 | 2018-02-28 |
| Antidepressants and Bone Mineral Density sertraline, citalopram, venlafaxine - Bone Mineral Density Quantitative Trait Locus 7 | Phase 3 | Completed | Guiyang Medical University | 203 | 2012-03-01 | 2014-07-01 |
Cataplexy (2) · Disorders of Excessive Somnolence (2) · Narcolepsy (2) · Anxiety Disorders (1) · Dementia (1) · Depression (1) · Fatigue (1) · Psychophysiologic Disorders (1) · Schizophrenia (1)
Axsome Therapeutics, Inc. (2) · Guiyang Medical University (1) · Hannover Medical School (1) · Vrije Universiteit Brussel (1)
Canada (2) · United States (2) · Belgium (1) · Germany (1)